Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Augmentin Patent Appeal On Fast-Track; GSK Braces For Generics

Executive Summary

GlaxoSmithKline could receive an appellate ruling on the validity of its Augmentin patents as early as January

You may also be interested in...



Novartis Pursuing Generic Biologics; Says Brand And Generic Lines Co-Exist

Novartis is positioning itself at the forefront of companies seeking approval of generic biologics with a pending application for human growth hormone

Novartis Pursuing Generic Biologics; Says Brand And Generic Lines Co-Exist

Novartis is positioning itself at the forefront of companies seeking approval of generic biologics with a pending application for human growth hormone

Geneva Generic Augmentin Distribution Limited To Warehousing Drug Chains

Drug wholesalers, independent pharmacists and hospital group purchasing organizations are protesting Geneva Pharmaceuticals' decision to directly sell its generic version of GlaxoSmithKline's Augmentin (amoxicillin/clavulanate) only to drug store chains with their own warehouses

Related Content

UsernamePublicRestriction

Register

PS039889

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel